BIONET Corp. (TPEX:1784)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
104.00
+3.00 (2.97%)
Mar 2, 2026, 1:30 PM CST
23.37%
Market Cap 5.08B
Revenue (ttm) 1.22B
Net Income (ttm) 69.82M
Shares Out 50.31M
EPS (ttm) 1.38
PE Ratio 73.15
Forward PE n/a
Dividend 1.42 (1.40%)
Ex-Dividend Date Oct 3, 2025
Volume 1,149,198
Average Volume 483,355
Open 99.10
Previous Close 101.00
Day's Range 98.90 - 107.50
52-Week Range 62.40 - 118.00
Beta 0.47
RSI 55.46
Earnings Date Mar 17, 2026

About BIONET

BIONET Corp. engages in the cell therapy business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells; and genetic testing services. It also provides storage and application of hematopoietic stem cells; regenerative medicine, analytical testing, clinical and preclinical research, and commercialized cell-derived products; and Exosome, a cell-free therapy. The company was founded in 1989 and is... [Read more]

Sector Healthcare
Founded 1989
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 1784
Full Company Profile

Financial Performance

In 2024, BIONET's revenue was 1.22 billion, an increase of 8.40% compared to the previous year's 1.13 billion. Earnings were 83.70 million, an increase of 6.76%.

Financial Statements

News

There is no news available yet.